Germany Respiratory Devices Market Size (2024 - 2029)

Germany Respiratory Devices Market Analysis

The German respiratory devices market is expected to register a CAGR of 5.5% over the forecast period.

Major respiratory devices, including ventilators, nebulizers, CPAP, BiPAP, and oxygen concentrators, were in high demand due to their widespread use in the case of COVID-19 patients. With the increased severity of COVID-19 in countries such as Germany, the use of breathing equipment has increased during the pandemic. The study published in the PLOS One Journal in January 2022 reported that during COVID-19, the use of non-invasive ventilation (NIV) increased substantially in Germany. The proportion of patients who only received NIV increased from 9% to 30%. As a result, the demand for respiratory equipment increased dramatically in Germany during the pandemic to treat COVID-19 patients, which had a favorable impact on the market's expansion. Furthermore, due to an increase in the prevalence of respiratory diseases and new product introductions, a similar trend is expected to continue over the forecast period.

The market is driven by the increase in the prevalence of respiratory disorders, such as COPD, TB, asthma, lung cancer, and sleep apnea, technological advancements, and a large patient population. For instance, a study published in the Journal of Asthma and Allergy in July 2022 reported that asthma is one of Germany's most common chronic diseases, affecting almost 4-5% of all adults and 10% of children each year. Thus, the high burden of asthma in the country is expected to increase the demand for respiratory devices, thereby driving the growth of the market studied over the forecast period.

Additionally, older people are more susceptible to respiratory disorders; therefore, an increase in this group is anticipated to fuel market expansion. Pneumonia, chronic obstructive pulmonary disease, asthma, lung cancer, and pulmonary embolism are examples of respiratory conditions associated with aging. According to the Germany Federal Statistical Office 2022 report, Germany has a population of approximately 83.2 million people. Of that, 16.2 million people are above the age of 67, which is anticipated to reach 21.4 million by 2040. Respiratory diseases are highly associated with the aging population; hence, an increase in the geriatric population is expected to drive the demand for respiratory devices in the country, thereby boosting market growth over the forecast period.

Furthermore, increasing R&D expenditure by innovators and generic players, technological advancements associated with respiratory devices, and the rising aging population are expected to boost the German respiratory devices market. For instance, in March 2022, researchers at FAU (Germany) and McGill University Québec (Canada) received EUR 225,000 (approximately USD 236,628) in funding from the Free State of Bavaria. The funding will be used to design a wearable device for monitoring the breathing of patients with chronic diseases such as asthma or bronchitis. The wearable device can automatically monitor respiratory function and reliably recognize symptom changes. Such technological advances and growing research and development activity are expected to boost market growth over the forecast period.

However, high costs associated with the devices may hamper the market growth to a certain extent.

Germany Respiratory Devices Industry Segmentation

Respiratory devices comprise respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. They also include a breathing apparatus used for resuscitation by forcing oxygen into the lungs of a person who has undergone asphyxia. The German respiratory devices market is segmented by type (diagnostic and monitoring devices (spirometers, sleep test devices, peak flow meters, pulse oximeters, and other diagnostic and monitoring devices), therapeutic devices (CPAP devices, BiPAP devices, humidifiers, nebulizers, ventilators, oxygen concentrators, inhalers, and other therapeutic devices), and disposables (masks, breathing circuits, and other disposables)). The report offers the value (in USD million) for the above segments.